Innovative neuroscience requires the combined efforts of scientific discovery, expert clinical development, and progressive commercialization strategies.

Partnerships and collaborations break the boundaries of any single organization, expanding the opportunities to develop and deliver innovative therapeutic solutions to patients.

NuPathe focuses on the development and commercialization of innovative therapeutics for underserved patients battling diseases of the central nervous system (CNS). Partnering plays an important role in achieving our objectives, and we aggressively seek new opportunities for partnership, licensing and collaboration in order to:

• Maximize the commercial opportunity for Zecuity through partnerships in the U.S. and territories throughout the world.
• Continue the commercialization and development of our pipeline candidates.
• Leverage our SmartRelief  and LAD (long-acting delivery) biodegradable implant drug delivery platforms through collaborative development.

At NuPathe, we are intent on providing medicines that make a difference in patients' lives. We believe that by addressing patient needs with outstanding products developed and commercialized efficiently and effectively, success will follow.

Why partner with NuPathe?

• NuPathe had a proven track record of developing and gaining approval of CNS products.
• NuPathe has an impressive pipeline of promising CNS candidates that address the needs of large populations of underserved patients.
• NuPathe’s proprietary drug delivery platforms have significant franchise opportunities.
• NuPathe is a highly motivated, experienced, and attentive partner.
• Our size and nimbleness allow us to be flexible and creative in our approach to collaborations.
• NuPathe manages its collaborations in an efficient and responsible manner through a dedicated senior-management business development team.